News Covis finally pulls preterm birth drug Makena from market Following FDA recommendation for withdrawal, Covid finally pulls premature birth drug Makena.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
